Download RSS feed: News Articles / In the Media / Audio
MIT researchers have developed a new drug capsule that can deliver doses of medication over the course of several weeks, reports Robby Berman for Slate. Berman explains that the star-shaped device is like “a little pharmacy stationed in the stomach, ready to dispense doses at the desired times.”
CSAIL researchers have developed a wearable system that can gauge the tone of a conversation based on a person’s speech patterns and vitals with 83 percent accuracy, writes Brian Barrett for Wired. The system could be useful for people with social anxiety or Asperger’s, Barrett explains.
Hallie Smith writes for Boston Magazine that CSAIL researchers have developed a system that can help detect of the tone of a conversation. The system could be especially useful “for those who struggle with emotional and social cues, such as individuals with Asperger’s Syndrome,” Smith explains.
Prof. Robert Langer speaks with Kathryn Nave of Wired about the future of drug delivery. Langer explains that a problem facing medical professionals is that many drugs are not taken regularly or as prescribed, and describes how he is developing a “long-acting pill that you could swallow to release the right drug dosage for weeks.”
Prof. James Collins has been named one of The Boston Globe’s “2016 Bostonians of the Year” for his work developing a paper-based test that can detect the Zika virus in just a few hours. Neil Swidey notes that Collins also developed a “workflow for how this new platform could be adapted to meet future crises.”
MIT researchers have found that flashing lights could potentially be used to stave off Alzheimer’s disease, writes Oscar Williams for The Huffington Post. “Light stimulation directed to the hippocampus, the part of the brain that processes memories, led to a reduction of…beta amyloid,” which is found in Alzheimer’s disease.
Financial Times reporter Clive Cookson writes that MIT researchers have found evidence that flashing lights could potentially be used as a noninvasive treatment for Alzheimer’s disease. The researchers found that “lights flashing on and off 40 times per second restored ‘gamma oscillation’ waves that were suppressed in the disease.”
MIT researchers have found that flashing light may reduce the buildup of beta amyloid protein in the brain, which is associated with Alzheimer’s disease, writes Michelle Roberts for the BBC News. The researchers hope that “clearing beta amyloid and stopping more plaques from forming could halt Alzheimer's and its symptoms.”
Writing for The Atlantic, Ed Yong spotlights a study by MIT researchers that identifies a potential new treatment for Alzheimer’s – using pulses of light to stimulate brain waves. Yong writes that the study “heralds a completely new approach to dealing with Alzheimer’s—changing neural activity, rather than delivering drugs or chemicals.”
MIT researchers have found that exposure to flickering lights at a precise frequency may help fight off Alzheimer’s disease, reports Melissa Healy for The Los Angeles Times. The technique recruits “neurons and other cell types in the brain to sort of enable the brain’s inner ability to repair itself,” explains Prof. Li-Huei Tsai, director of the Picower Institute.
Guardian reporter Hannah Devlin writes about a new study by MIT researchers that shows that strobe lighting can reduce levels of toxic proteins found in Alzheimer’s disease. The researchers found that “exposure to flickering light stimulated brain waves, called gamma oscillations, that are known to be disturbed in Alzheimer’s patients.”
A new drug delivery system developed by MIT researchers may help eradicate malaria and could boost medication adherence, writes Rachel Zimmerman for WBUR’s Bostonomix. "People don't take their medicines and this might be a way, someday, for Alzheimer's patients to have much better treatments and people with mental health diseases to have much better treatments," says Prof. Langer.
MIT researchers have devised a capsule that can deliver medications over extended periods of time, and could be useful in halting the spread of malaria. The Economist notes that the device could be a “useful addition to the armory being deployed against malaria. And that, alone, could save many lives a year.”
Bob Tedeschi writes for STAT that MIT researchers have developed a device that can remain in the stomach for up to two weeks, gradually releasing medication. “The capsule represents the latest effort to solve a major flaw in drug delivery,” Tedeschi explains. “Because the human stomach clears its contents multiple times daily, pill takers must dose themselves frequently.”
MIT researchers have developed a new drug delivery capsule that can deliver medication over extended periods of time, reports Claire Maldarelli for Popular Science. Once in the stomach, the capsule opens into a star shape, which “prevents the pill from leaving the stomach and entering the small intestine.”